Sorrento Therapeutics, Inc. - FORM 10-K - EX-21.1 - March 2, 2020

Attached files

file filename
EX-4.23 - EX-4.23 - Sorrento Therapeutics, Inc.exhibit423q42019.htm
EX-23.1 - EX-23.1 - Sorrento Therapeutics, Inc.exhibit231q42019.htm
EX-31.1 - EX-31.1 - Sorrento Therapeutics, Inc.exhibit311q42019.htm
EX-31.2 - EX-31.2 - Sorrento Therapeutics, Inc.exhibit312q42019.htm
10-K - 10-K - Sorrento Therapeutics, Inc.srne-20191231.htm
EX-10.32 - EX-10.32 - Sorrento Therapeutics, Inc.exhibit1032-10k.htm
EX-32.1 - EX-32.1 - Sorrento Therapeutics, Inc.exhibit321q42019.htm

Exhibit 21.1
Subsidiaries of Sorrento Therapeutics, Inc.
Name
State or
Jurisdiction
of Incorporation or
Organization
Concortis Biosystems, Corp.
Delaware
Ark Animal Health, Inc.
Delaware
TNK Therapeutics, Inc.
Delaware
BioServ Corporation
Delaware
Scilex Holding Company Delaware
Semnur Pharmaceuticals, Inc.Delaware
Scilex Pharmaceuticals Inc.
Delaware
Levena Suzhou Biopharma Co., Ltd.
People’s Republic of China
Sorrento Therapeutics (Shanghai) Co., Ltd.
People’s Republic of China
Nanjing Levena Biopharma Co. Ltd.
People’s Republic of China
Virttu Biologics Limited
England and Wales
Scintilla Health, Inc. Delaware
 


Sorrento Therapeutics, Inc. Reports